Αποτελέσματα Αναζήτησης
This chapter assimilates the best practices for delivering injections in health-care and related facilities. It is based on a range of evidence and expands the scope of the WHO publication Best infection control practices for intradermal, subcutaneous, and intramuscular needle injection (7).
M-M-R II may be administered by the subcutaneous or intramuscular route. Some vaccines are approved by the Food and Drug Administration (FDA) for administration by the Pharmajet Stratis needle-free injection system.
13 Αυγ 2023 · Insure intramuscular positioning of the needle via confirming restricted side-to-side movement of the needle as opposed to when the needle is in the subcutaneous plane.
Subcutaneous injections are administered at a 45-degree angle, usually into the thigh for infants aged <12 months and in the upper-outer triceps area of persons aged ≥12 months. Subcutaneous injections may be administered into the upper-outer triceps area of an infant if necessary.
This Guideline covers normal human immunoglobulin for subcutaneous and /or intramuscular administration defined by the relevant European Pharmacopoeia monographs. It does not apply to fragmented or chemically modified IgG.
14 Ιουλ 2017 · WHO has also published the WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health care settings, the first evidence-based policy document that specifically addresses the use of safety-engineered injection devices for therapeutic injections.
The purpose of this core SmPC is to provide applicants and regulators with harmonised guidance on the information to be included in the Summary of product characteristics (SmPC) for a human normal immunoglobulin for subcutaneous and/or intramuscular administration.
